Science, medicine, and the future: assessing thrombotic risk.
作者信息
Laffan M, Tuddenham E
机构信息
Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN.
出版信息
BMJ. 1998 Aug 22;317(7157):520-3. doi: 10.1136/bmj.317.7157.520.
Abstract
摘要
相似文献
1
Science, medicine, and the future: assessing thrombotic risk.
BMJ. 1998 Aug 22;317(7157):520-3. doi: 10.1136/bmj.317.7157.520.
2
[Factor V Leiden and activated protein C resistance].
Rev Med Brux. 1997 Jun;18(3):97-102.
3
Molecular risk factors for thrombosis.血栓形成的分子危险因素。
Thromb Haemost. 1999 Aug;82(2):601-9.
4
Activated protein C resistance--a major risk factor for thrombosis.活化蛋白C抵抗——血栓形成的主要危险因素。
Eur J Clin Chem Clin Biochem. 1997 Jul;35(7):501-16.
5
Dual genetic abnormality in the coagulation pathway as a cause of familial thrombophilia.凝血途径中的双重基因异常作为家族性血栓形成倾向的一个原因。
J Assoc Physicians India. 2009 Jul;57:529-30.
6
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.凝血因子V的促凝和抗凝特性在血栓形成和出血性疾病发病机制中的作用
Int J Lab Hematol. 2016 May;38 Suppl 1:4-11. doi: 10.1111/ijlh.12508. Epub 2016 May 9.
7
[Activated protein C resistance and mutation of coagulation factor V].[活化蛋白C抵抗与凝血因子V突变]
Arch Mal Coeur Vaiss. 1996 Jun;89(6):669-70.
8
[Study of the Leiden mutation (factor VQ 506), the most frequent cause of thrombophilia, in 116 thrombosis patients].
Orv Hetil. 1997 Nov 2;138(44):2797-800.
9
No association between thrombosis and factor V gene polymorphisms in Chinese Han population.中国汉族人群中血栓形成与凝血因子V基因多态性之间无关联。
Thromb Haemost. 2003 Mar;89(3):446-51.
10
Inherited prethrombotic disorders and infectious purpura.
Thromb Haemost. 1996 Jun;75(6):899-901.
引用本文的文献
1
Review of thromboembolic prophylaxis in patients attending Cork University Hospital.科克大学医院就诊患者的血栓栓塞预防评估。
Int J Clin Pharm. 2013 Jun;35(3):439-46. doi: 10.1007/s11096-013-9760-5. Epub 2013 Mar 15.
2
Factor XII deficiency and recurrent sixth nerve palsy.因子Ⅻ缺乏与复发性展神经麻痹。
Br J Ophthalmol. 2003 Mar;87(3):369-70. doi: 10.1136/bjo.87.3.369.
3
Cerebral sinus thrombosis and oral contraceptives. There are limits to predictability.脑静脉窦血栓形成与口服避孕药。预测存在局限性。
BMJ. 1998 Aug 22;317(7157):483-4. doi: 10.1136/bmj.317.7157.483.
本文引用的文献
1
An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).甲型血友病与因子V（莱顿）联合的体外分析。
Blood. 1997 Oct 15;90(8):3067-72.
2
Inherited thrombophilia: Part 2.遗传性血栓形成倾向：第2部分。
Thromb Haemost. 1996 Dec;76(6):824-34.
3
Inherited thrombophilia: Part 1.遗传性血栓形成倾向：第1部分。
Thromb Haemost. 1996 Nov;76(5):651-62.
4
5
Factor V Leiden: should we screen oral contraceptive users and pregnant women?凝血因子V莱顿突变：我们应该对口服避孕药使用者和孕妇进行筛查吗？
BMJ. 1996 Nov 2;313(7065):1127-30. doi: 10.1136/bmj.313.7065.1127.
6
Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.遗传性抗凝血酶缺乏家族中的凝血因子V莱顿突变（FV R506Q）
Thromb Haemost. 1996 Mar;75(3):417-21.
7
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.由于一种先前未被认识的机制导致的家族性血栓形成倾向，其特征为对活化蛋白C的抗凝反应不佳：活化蛋白C辅因子的预测。
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004-8. doi: 10.1073/pnas.90.3.1004.
8
Mutation in blood coagulation factor V associated with resistance to activated protein C.凝血因子V突变与活化蛋白C抵抗相关。
Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0.
9
10
Activation markers of coagulation.
Baillieres Clin Haematol. 1994 Sep;7(3):523-40. doi: 10.1016/s0950-3536(05)80097-6.
Zotero 插件